FDA Logo links to FDA home page
Center for Biologics Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Biologics Evaluation and Research
 HHS Logo links to Department of Health and Human Services website

FDA Home Page | CBER A-Z Index | CBER Search | Contact CBER | CBER Home Page

horizonal rule
CBER links to product areas
CBER links
horizonal rule

Recall of Albumin (Human) 5%, Buminate

horizonal rule

DATE RECALL INITIATED:

July 18, 2001

PRODUCT / LOT NUMBER / EXPIRATION DATE:

Albumin (Human) USP, 5% Solution, Buminate 5%, 250 mL

29240641AA     12/2/2002

MANUFACTURER:

Baxter Healthcare Corporation
Glendale, CA

REASON:

Subsequent to release of this product Baxter performed a non-required PCR test of the plasma manufacturing pool from which this product was derived. A low-level positive PCR test result for HIV-2 was obtained for the fourth centrifugation run of the plasma manufacturing pool. The manufacturing process includes steps for viral inactivation. No adverse events associated with this specific lot have been reported.

horizonal rule

The information in this listing reflects CBER's best efforts to communicate information that has been reported to FDA. Its accuracy and comprehensiveness cannot be guaranteed.

 

 
horizonal rule